The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dobak John since 2020.
This trader's CIK number is 1787176.
At the time of last reporting, Dobak John was the Chief Executive Officer of Dermtech, Inc.. (stock ticker symbol DMTK).
Also see all insider trading activities at Dermtech, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DMTK | 0 | $0 | 25,514 | $102,339 | 0 | $0 |
| 2022 | DMTK | 0 | $0 | 4,673 | $62,597 | 0 | $0 |
| 2021 | DMTK | 0 | $0 | 89,575 | $3,989,163 | 0 | $0 |
| 2020 | DMTK | 0 | $0 | 3,256 | $36,276 | 155,720 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-13 | DMTK | Sale | 1,559 | 3.26 | 5,082 |
| 2023-03-07 | DMTK | Sale | 23,955 | 4.06 | 97,257 |
| 2022-03-11 | DMTK | Sale | 1,326 | 14.55 | 19,293 |
| 2022-03-07 | DMTK | Sale | 2,561 | 13.03 | 33,369 |
| 2022-03-08 | DMTK | Sale | 786 | 12.64 | 9,935 |
| 2021-12-13 | DMTK | Sale | 1,964 | 16.71 | 32,818 |
| 2021-12-08 | DMTK | Sale | 1,119 | 18.46 | 20,656 |
| 2021-09-13 | DMTK | Sale | 1,899 | 36.19 | 68,724 |
| 2021-09-08 | DMTK | Sale | 1,162 | 36.19 | 42,052 |
| 2021-07-01 | DMTK | Sale | 12,500 | 41.22 | 515,287 |
| 2021-06-11 | DMTK | Sale | 7,651 | 41.08 | 314,326 |
| 2021-06-02 | DMTK | Sale | 9,530 | 40.00 | 381,200 |
| 2021-06-01 | DMTK | Sale | 2,970 | 40.22 | 119,444 |
| 2021-04-27 | DMTK | Sale | 25,000 | 51.35 | 1,283,750 |
| 2021-04-12 | DMTK | Sale | 25,000 | 46.88 | 1,171,875 |
| 2021-03-08 | DMTK | Sale | 780 | 50.04 | 39,031 |
| 2020-12-08 | DMTK | Sale | 786 | 11.86 | 9,321 |
| 2020-09-10 | DMTK | Sale | 2,470 | 10.91 | 26,955 |
| 2019-12-31 | DMTK | Option Ex | 155,720 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dobak John (Chief Executive Officer of Dermtech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.